Showing results (921-930 of 3,659) with videos related to

Sort By:
Pageof 366
Breast (Edinburgh, Scotland)|November 13, 2013
Patient information on breast reconstruction in the era of the world wide web. A snapshot analysis of information available on youtube.comM L H Tan, K Kok, V Ganesh, et al.
Breast (Edinburgh, Scotland)|March 2, 2012
Post-mastectomy pain syndrome: incidence and risksErica Alves Nogueira Fabro, Anke Bergmann, Blenda do Amaral E Silva, et al.
Breast (Edinburgh, Scotland)|March 6, 2012
Radiofrequency thermoablation in locally advanced breast cancerGiuseppe Santoro, Mario Avossa, Marcello Della Corte
Breast (Edinburgh, Scotland)|February 23, 2012
Lack of association of ADH1C genotype with breast cancer susceptibility in Caucasian population: a pooled analysis of case-control studiesLiping Wang, Ying Zhang, Dapeng Ding, et al.
Breast (Edinburgh, Scotland)|July 8, 2014
Primary systemic treatment and concomitant low dose radiotherapy for breast cancer: final results of a prospective phase II studyLuigia Nardone, Barbara Diletto, Maria Carmen De Santis, et al.
Breast (Edinburgh, Scotland)|September 16, 2015
Intensity modulated radiotherapy with simultaneous integrated boost vs. conventional radiotherapy with sequential boost for breast cancer - A preliminary resultHsin-Hua Lee, Ming-Feng Hou, Hung-Yi Chuang, et al.
Breast (Edinburgh, Scotland)|May 17, 2016
Risk factors for lymphoedema in women with breast cancer: A large prospective cohortS L Kilbreath, K M Refshauge, J M Beith, et al.
Breast (Edinburgh, Scotland)|May 31, 2016
Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based dataArnaud Seigneurin, José Labarère, Olivier François, et al.
Breast (Edinburgh, Scotland)|May 31, 2016
Effects of locoregional radiotherapy in patients with metastatic breast cancerGeovanne Pedro Mauro, Heloisa de Andrade Carvalho, Silva Radwanski Stuart, et al.
Breast (Edinburgh, Scotland)|April 8, 2016
Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer - Results from the prospective multi-center randomized ADEBAR trialLukas Schwentner, Nadia Harbeck, Susanne Singer, et al.
Pageof 366